Drug reference

dihydroartemisinin

Antimalarial agent

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

FDA category + note

Mechanism

Not yet extracted

Pharmacokinetics

Half-life

short half-lives

Side effects

Common

nauseavomitinganorexiacontact dermatitis

Serious

neurotoxicity (ataxia, convulsions)

Pregnancy & lactation

Pregnancy

Drug interactions

Mefloquine

Moderate

Textbook

Increased mefloquine absorption.

Source: Harrison 22e · p1740

Other Unclassified drugs

5-9-tetrahydrocannabinol

adrenochrome monosemicarbazone

0 brands

Ask House about dihydroartemisinin

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team